Search research articles
Contact Us
Filters
Showing results (671-680 of 1,678) with videos related to
Page
of 168
Sort By:
JAMA
|
May 14, 1982
Aletta Jacobs
R A Kyle, M A Shampo
JAMA
|
May 14, 1982
Gerhard Domagk
R A Kyle, M A Shampo
JAMA
|
December 12, 1980
Tenley Albright
M A Shampo, R A Kyle
JAMA
|
January 9, 1981
Earle Christmas Grafton Page
M A Shampo, R A Kyle
JAMA
|
March 13, 1981
Marcello Malpighi
M A Shampo, R A Kyle
JAMA
|
February 20, 1981
Fritz Haber
M A Shampo, R A Kyle
Mayo Clinic Proceedings
|
May 3, 2024
Sir Wilfred Thomason Grenfell: Medical Pioneer in Newfoundland and Labrador
David P Steensma, Robert A Kyle
American Journal of Hematology
|
May 1, 1992
Mu-heavy chain disease: presentation as a benign monoclonal gammopathy
D L Wahner-Roedler, R A Kyle
Best Practice & Research. Clinical Haematology
|
July 20, 2005
Heavy chain diseases
Dietlind L Wahner-Roedler, Robert A Kyle
Journal of Oncology Practice
|
March 9, 2018
Role of Bone-Modifying Agents in Multiple Myeloma: American Society of Clinical Oncology Clinical Practice Guideline Update Summary
Kenneth Anderson, Nofisat Ismaila, Robert A Kyle
Page
of 168
Search research articles
Search
Showing results (671-680 of 1,678) with videos related to
Sort By:
Page
of 168
JAMA
|
May 14, 1982
Aletta Jacobs
R A Kyle, M A Shampo
JAMA
|
May 14, 1982
Gerhard Domagk
R A Kyle, M A Shampo
JAMA
|
December 12, 1980
Tenley Albright
M A Shampo, R A Kyle
JAMA
|
January 9, 1981
Earle Christmas Grafton Page
M A Shampo, R A Kyle
JAMA
|
March 13, 1981
Marcello Malpighi
M A Shampo, R A Kyle
JAMA
|
February 20, 1981
Fritz Haber
M A Shampo, R A Kyle
Mayo Clinic Proceedings
|
May 3, 2024
Sir Wilfred Thomason Grenfell: Medical Pioneer in Newfoundland and Labrador
David P Steensma, Robert A Kyle
American Journal of Hematology
|
May 1, 1992
Mu-heavy chain disease: presentation as a benign monoclonal gammopathy
D L Wahner-Roedler, R A Kyle
Best Practice & Research. Clinical Haematology
|
July 20, 2005
Heavy chain diseases
Dietlind L Wahner-Roedler, Robert A Kyle
Journal of Oncology Practice
|
March 9, 2018
Role of Bone-Modifying Agents in Multiple Myeloma: American Society of Clinical Oncology Clinical Practice Guideline Update Summary
Kenneth Anderson, Nofisat Ismaila, Robert A Kyle
Page
of 168